Blood Journal

Overview
Identity
View All

publication venue for

How I treat older patients with relapsed/refractory diffuse large B-cell lymphoma.. 145:277-289. 2025
How I Treat Anemia in Older Adults.. 143:205-213. 2024
How I prevent GVHD in high-risk patients: posttransplant cyclophosphamide and beyond.. 141:49-59. 2023
Prebiotic galactooligosaccharides interact with mouse gut microbiota to attenuate acute graft-versus-host disease.. 140:2300-2304. 2022
Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML.. 139:3546-3557. 2022
HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide.. 139:1452-1468. 2022
Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning.. 139:608-623. 2022
Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study.. 137:1527-1537. 2021
Geriatric assessment and survival among older adults receiving postremission therapy for acute myeloid leukemia.. 136:2715-2719. 2020
Cost-effectiveness of first-line vs third-line ibrutinib in patients with untreated chronic lymphocytic leukemia.. 136:1946-1955. 2020
House calls for stem cell transplant patients during the COVID-19 pandemic.. 136:370-371. 2020
The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD.. 136:130-136. 2020
How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide.. 134:1802-1810. 2019
TNF-α-driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging.. 134:727-740. 2019
Gait speed, grip strength, and clinical outcomes in older patients with hematologic malignancies.. 134:374-382. 2019
The genomic landscape of plasma cells in systemic light chain amyloidosis.. 132:2775-2777. 2018
Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma.. 131:301-310. 2017
Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphoma.. 130:2180-2185. 2017
Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma.. 128:1821-1828. 2016
Should IGHV status and FISH testing be performed in all CLL patients at diagnosis? A systematic review and meta-analysis.. 127:1752-60. 2016
Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy.. 127:200-7. 2015
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide.. 125:3024-31. 2015
The efficacy of ibrutinib in the treatment of Richter syndrome.. 125:1676-8. 2015
Paraneoplastic thrombocytosis: the secrets of tumor self-promotion.. 124:184-7. 2014
Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project.. 122:590-7. 2013
Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel.. 120:5041-9. 2012
TLR7 enables cross-presentation by multiple dendritic cell subsets through a type I IFN-dependent pathway.. 118:3028-38. 2011
Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases.. 113:1689-98. 2008
Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review.. 113:1231-40. 2008
Notch1 and TGFbeta1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells.. 112:1813-21. 2008
The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention.. 112:504-10. 2008
The thymic theme of acetylcholinesterase splice variants in myasthenia gravis.. 109:4383-91. 2007
The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1.. 105:1170-8. 2004
Correlation between erythrocyte CR1 reduction and other blood proteinase markers in patients with malignant and inflammatory disorders.. 75:1699-704. 1990
Age as a prognostic factor in multiple myeloma.. 73:-. 1989
Cooperative effect of tumor necrosis factor and gamma-interferon on chemotactic peptide receptor expression and stimulus-induced actin polymerization in HL-60 cells.. 71:1062-7. 1988
Comparison of two long-term chemotherapy regimens, with or without agents to modify skeletal repair, in multiple myeloma.. 63:639-48. 1984
Combination chemotherapy with intermittent 1-3-bis(2-chloroethyl)1-nitrosourea (BCNU), cyclophosphamide, and prednisone for multiple myeloma.. 54:824-36. 1979
Arsenic-induced bone marrow toxicity: ultrastructural and electron-probe analysis.. 53:820-7. 1979
Hairy cell leukemia: cellular characteristics including surface immunoglobulin dynamics and biosynthesis.. 53:764-5. 1979
In vitro kinetics of immunoglobulin synthesis and secretion by nonsecretory human myeloma cells.. 50:1031-8. 1977
Human lymphocyte motility: normal characteristics and anomalous behavior of chronic lymphocytic leukemia cells.. 48:717-29. 1976
Intranuclear inclusions in Bence Jones lambda plasma cell myeloma.. 45:131-9. 1975
A monoclonal IgM with antibodylike specificity for phospholipids in a patient with lymphoma.. 43:493-504. 1974
Pharmacological inhibition of VIP signaling enhances antiviral immunity and improves survival in murine cytomegalovirus-infected allogeneic bone marrow transplant recipients 2013
Pharmacological inhibition of VIP signaling enhances antiviral immunity and improves survival in murine cytomegalovirus-infected allogeneic bone marrow transplant recipients 2013